Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Works of Rick Martin being referenced
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
2010
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rick Martin | 962 | 508 | 163 | 367 | 11 | 1.1k | |
| Müge Güçsavaş‐Çalıkoğlu | 772 | 412 | 140 | 271 | 10 | 1.1k | |
| Elke Miebach | 963 | 512 | 180 | 284 | 15 | 1.0k | |
| M. J. Valstar | 731 | 351 | 127 | 162 | 16 | 922 | |
| Richard H. Hoft | 634 | 338 | 111 | 211 | 16 | 951 | |
| Robin Winkler Doroshow | 627 | 462 | 111 | 208 | 17 | 1.0k | |
| William G. Mackenzie | 818 | 348 | 167 | 303 | 25 | 1.1k | |
| Ed Wraith | 698 | 236 | 105 | 195 | 24 | 885 | |
| J. E. Wraith | 654 | 228 | 103 | 422 | 34 | 1.2k | |
| A. J. J. Reuser | 966 | 152 | 278 | 758 | 19 | 1.1k | |
| C B Whitley | 548 | 212 | 101 | 207 | 29 | 952 |
All Works
Loading papers...